China Pharmaceutical Industry Association (CPIA) You have a very long history in the Chinese pharmaceutical industry, first in the joint venture company Xian-Janssen and then in the China National Pharmaceutical Group. Could you highlight the main evolutions of the Chinese pharmaceutical industry through these fast-changing times? It is indeed true that we have undergone tremendous…
PharmaLegacy Could you give us some personal background and tell us why you choose to come to the CRO side after a successful career at a multinational? A lot of people ask why I chose to make this transition after being at a pretty good position at Procter & Gamble, with…
Kampar Kampar began its operations in Chile in 2005. What have been the main milestones and achievements of the company in the last five years? Our main achievement since the creation of Kampar has been our strong market penetration. We have certified products coming from specific sources with norms and standards…
Biotech Pharmaceutical Co Ltd Could you please introduce the history and main characteristics of Biotech Pharmaceutical? Biotech Pharmaceutical was established in the year 2000, so we are a relatively young company for biopharmaceutical products by Chinese standards. However, we were the first company in China to discover, develop, manufacture and market monoclonal antibodies. Before…
The Balloch Group What initially attracted you to China and what kept you here over the years? I initially became interested in China during university where I studied the country and wrote a masters thesis on China. This was during the Cultural Revolution so it wasn’t easy to come to China in those…
Beaufour IPSEN China Your background before joining Beaufour Ipsen is quite unique among country managers of pharmaceutical companies: working many years in academia and focused very much on Asian studies. What brought you to the pharmaceutical industry? I have a very long personal history with China, starting back in my student days. I…
COFEPRIS It’s been one year since you were appointed as Federal Commissioner of COFEPRIS in March 2011. What have been the biggest challenges you’ve faced within this time? The biggest challenge was to familiarize myself with the new agency, which has very wide powers as it regulates many industries. COFEPRIS regulates…
Pharma Investi Chile As the President of ASILFA what would you say are the main drivers and challenges for the Chilean pharmaceutical industry today? Chile today is moving to implement a new healthcare system. The government is trying to address the inefficiencies of the public system today and to modernize it so that…
R&D-based Pharmaceutical Association Committe You have a long experience in the Chinese pharmaceutical market, and in particular you saw it evolve tremendously over the last 10 years. From a management perspective, would you say that it is easier or harder to tackle today or a decade ago? In my view, the Chinese market is…
PMG Pharma How has your previous professional experience enriched you to run PMG today? And what would you say have been the main milestones and achievements of PMG Pharma since its creation? I should start by mentioning that my professional background starts with a long term experience in a multinational company –…
Merck Sharp & Dohme Chile What have been MSD’s major milestones and achievements since your establishment in Chile in 1995? We have recently gone through a global merger with Schering Plough, which occurred exactly a year ago. With this in mind, the first milestone that I can mention is the integration of these two relatively…
Medicilon/MPI Preclinical Research Shanghai You completed your higher education in the US and worked there for a period afterwards; what caused you to move back to China and start this company? A lot of people are now returning to China after gaining extensive experience in the US. I personally enjoyed the vast experience that…
See our Cookie Privacy Policy Here
